PeerView | Pulmonary/Respiratory Medicine

Free CME from PeerView

Pulmonary/Respiratory Medicine CME

PVI, PeerView Institute for Medical Education

Gaining an Advantage Over NSCLC: How to Achieve the Greatest Benefit With Immunotherapy From Advanced to Early Disease

David P. Carbone, MD, PhD

June 27, 2022

PVI, PeerView Institute for Medical Education

The Power of Interprofessional Teams in SSc-ILD: From Diagnosis Through Management

Lisa H. Lancaster, MD

June 20, 2022

PVI, PeerView Institute for Medical Education

Find the Targets, Treat With Precision: Modern Principles and New Advances in Biomarker-Driven Lung Cancer Care

Stephen V. Liu, MD

June 04, 2022

PVI, PeerView Institute for Medical Education

Targeting TIGIT to Extend Immunotherapy Benefits to More Cancer Patients: A Strategy to Amplify Immune Response and Enhance or Restore Antitumor Activity

Zev A. Wainberg, MD

May 30, 2022

PVI, PeerView Institute for Medical Education

Airway Inflammation Isn’t the Only Problem: Shining a Light on the Role of Airway Hyper-Responsiveness in Severe Asthma

Jonathan Corren, MD

May 25, 2022

Medical Learning Institute, Inc.

How to Integrate Perioperative Immunotherapy Into Multimodal Treatment Plans to Improve Outcomes in Resectable NSCLC

Nasser Altorki, MD

May 14, 2022

PVI, PeerView Institute for Medical Education

Tackling the Challenge of Treating Severe Asthma: Taking Aim at the Airway Epithelium

Professor Andrew Menzies-Gow

May 03, 2022

PVI, PeerView Institute for Medical Education

Tackling the Practicalities of Antibody–Drug Conjugate Therapy for Solid Tumors: Improving Clinical Care With HER2-, HER3-, and TROP2-Targeted Therapies

Linda Ahn, MSN, ANP-BC, AOCNP

April 27, 2022

PVI, PeerView Institute for Medical Education

Weighing the Evidence, Parsing the Practicalities: Integrating New Treatment Options Into the SCLC Treatment Arsenal to Improve Patient Outcomes in Oncology Practice

Jacob Sands, MD

April 26, 2022

PVI, PeerView Institute for Medical Education

Expanding Options, Lingering Questions: How to Select the Right Immunotherapy for First-Line Treatment of Advanced NSCLC

Mark A. Socinski, MD

April 19, 2022

Medical Learning Institute, Inc.

How I Think, How I Treat—Assessing, Managing, and Engaging Patients With Uncontrolled, Moderate to Severe Asthma: Comparing Approaches With Experts Around the World

Michael E. Wechsler, MD

April 11, 2022

PVI, PeerView Institute for Medical Education

Parsing the Practicalities of Pathologic Response Assessment After Neoadjuvant Immunotherapy to Facilitate Progress in Early-Stage Cancers

Prof. Solange Peters, MD, PhD

April 09, 2022

Medical Learning Institute, Inc.

Decoding the Latest Evidence and Practical Recommendations on Biomarker Testing for New Therapeutic Options Targeting HER2, HER3, and TROP2 in Solid Tumors

Kurt A. Schalper, MD, PhD

March 22, 2022

Medical Learning Institute, Inc.

Progress and Practicalities in Immunotherapy Biomarker Testing and Pathologic Response Assessment in Solid Tumors: What’s New and What You Need to Know and Do

Kurt A. Schalper, MD, PhD

March 21, 2022

Pages